---

• n  recurrent large circumscribed areas of subcutaneous edema; onset is sudden and it disappears within 24 hours; seen mainly in young women, often as an allergic reaction to food or drugs

• atrophedema
• giant hives
• periodic edema
• Quincke's edema

News & Articles

---

• Santarus says FDA accepts Ruconest application
  Santarus Inc. and Pharming Group said Tuesday that the Food and Drug Administration accepted their marketing application for the hereditary angioedema drug Ruconest, and will make a decision in 10 months. ...
  June 18, 2013 - Associated Press via Yahoo! News
• Santarus and Pharming Announce FDA Acceptance for Review of RUCONEST (Recombinant Human C1 Esterase Inhibitor ...
  SAN DIEGO & LEIDEN, Netherlands--(BUSINESS WIRE)--Santarus SNTS and Pharming Group NV today announced that the U.S. FDA has accepted the BLA filing for RUCONEST, the first recombinant C1 esterase inhibitor for treating hereditary angioedema.
  June 18, 2013 - Business Wire